Skip to main content
Raphas Co., Ltd. logo

Raphas Co., Ltd. — Investor Relations & Filings

Ticker · 214260 ISIN · KR7214260002 KO Manufacturing
Filings indexed 328 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 214260

About Raphas Co., Ltd.

https://www.raphas.com/

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period January 1 to March 31, 2026 (1st quarter) and contains detailed financial, corporate, and business information for that interim period. It is the full quarterly report itself, not merely an announcement. Therefore, it matches the definition of an Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a “주식등의 대량보유상황보고서(일반)” filed under Korea’s Capital Markets and Financial Investment Business Act, detailing a person’s and related parties’ significant shareholdings, changes in holdings, percentages before and after thresholds, and reasons for the changes. This matches the definition of a Major Shareholding Notification (MRQ).
2026-05-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean "임원ㆍ주요주주 특정증권등 소유상황보고서" filed with the Securities and Futures Commission and Korea Exchange, detailing personal share ownership and trades by an executive (Jeong Do Hyeon). It reports dates, share counts, ratios, and transaction details—matching an insider share transaction report. This corresponds to the Director’s Dealing category.
2026-05-12 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 96% confidence The document is a regulatory notice entitled "사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고," detailing the appointment and dismissal of an outside director. This clearly corresponds to an announcement of changes in the company's board of directors, fitting the Board/Management Information category (MANG).
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the results of the 2026 annual general shareholders’ meeting (“정기주주총회결과”) including votes on financial statements approval, dividend resolutions, director elections, and detailed voting percentages. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement, Code DVA.
2026-03-30 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 85% confidence The document is titled “의결권 대리행사 권유 참고서류” which translates to “Proxy Solicitation Reference Materials.” It contains the full corrected financial statements and details distributed to shareholders to solicit their votes at a general meeting. This clearly matches the definition of a Proxy Solicitation & Information Statement (PSI) rather than an earnings release, annual report, or mere announcement. It is also a full report (over 60,000 characters), not a short notice pointing to an attachment (so not an RPA). Therefore the correct classification is PSI.
2026-03-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.